Ethoxylates Market To Witness Growth Owing To Increasing Demand In Detergents And Personal Care Products By The Consumers Till 2025: Grand View Research, Inc.

July 31, 2017August 1, 2017 / Market Research And Consulting Services / Leave a comment

The global ethoxylates market size is expected to reach USD 14.75 Billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness growth at 3.5% CAGR owing to increasing demand in detergents and personal care products by the consumers due to increasing awareness regarding hygiene & health care coupled with exceptional cleansing properties exhibited by ethoxylates.

Growing use of the product in pharmaceutical industry as an ingredient in ointments and emulsions is expected to drive the market growth over the forecast period. In addition, high dependence on ethoxylates based herbicides and insecticides by the farmers, in a bid to increase the crop yield is likely to benefit the market growth.

Technological advancements in the field of metal manufacturing is expected to lead to an increasing demand for the product as a constituent of metal working fluid formulations for foam control is expected to lead to an increase in the demand for the product. The rising use of the product as wetting agent in industrial applications is also expected to have a substantial impact on the demand for the product. Superior properties of the product such as high oxidation resistance, low rinse and excellent de-emulsification has enabled their use for petroleum refining.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/ethoxylates-market

Further key findings from the report suggest:

Alcohol ethoxylates segment is expected to emerge as the fastest growing product segment, exhibiting a CAGR of 4.2% over the period 2017-2025 Due to increasing demand for detergents, household products
Pharmaceutical application segment is expected to reach USD 909.0 Million by 2025 owing to increasing use of ethoxylates for high quality emulsifiers in the manufacturing of ointments and emulsions
Asia Pacific is expected to exhibit highest growth owing to the presence of rapidly developing economies such as India, China, Japan and South Korea coupled with growing manufacturing base involved in the production of cleaning products
Foam control & wetting agents segment is expected to register a market growth of CAGR of 4.4% over the period 2017-2025 on account of the development of advanced processing techniques resulting in improved quality of the products used in household and I&I cleaning
The industry is characterized by the presence of a large number of major players involved in the production of high volumes of ethoxylates leading to notable market shares

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/organic-chemicals-and-compounds

Grand View Research has segmented the ethoxylates market on the basis of product, application, end-use and region:

Ethoxylates Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

Alcohol Ethoxylates
Fatty Amine Ethoxylates
Fatty Acid Ethoxylates
Ethyl Ester Ethoxylates
Glyceride Ethoxylates
Others

Ethoxylates Application Outlook Volume, Kilo Tons; (Revenue, USD Million, 2014 – 2025)

Household & Personal Care
Institutional & Industrial Cleaning
Pharmaceutical
Agrochemicals
Oilfield Chemicals
Others

Ethoxylates End-use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

Detergents
Personal Care
Ointments & Emulsions
Herbicides
Insecticides
Foam Control & Wetting Agents
Lubricants and Emulsifiers
Others

Ethoxylates Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

North America
- S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
Asia Pacific
- China
- India
- Japan
- South Korea
Central & South America
- Brazil
- Argentina
Middle East & Africa
- South Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-ethoxylates-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

Erythropoietin Drugs Market Is Expected To Witness CAGR Of 11.5% From 2014 To 2025: Grand View Research, Inc.

July 31, 2017 / Market Research And Consulting Services / Leave a comment

The global erythropoietin (EPO) drugs market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of this market.

According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.

Introduction of novel drugs and their cheaper biosimilar formulations with enhanced efficacy and cost-effectiveness is also expected to serve this industry with lucrative opportunities. For instance, development of numerous biosimilars in the European market is expected to gain traction and increase their usage rates, owing to associated benefits such as less time required for approval, cost-efficiency, and enhanced therapeutic effect.

Companies are involved in extensive R&D initiatives for development of innovative molecules and discovering new therapeutic areas for existing drugs. For instance, in April 2016, Sandoz received approval from the European Commission for use of its biosimilar Binocrit in nephrology indications, thereby extending the therapeutic area of its product portfolio.

Moreover, many of the industry players in the U.S., Europe, and Asia Pacific are involved in the development of new biosimilars. For example, Biocon’s subsidiary Syngene International entered into an agreement with Bristol-Myers Squibb to extend their drug discovery and development program in India. This enables Biocon to enhance its erythropoietin drugs portfolio. Expected product approvals in the coming years are anticipated to fuel market growth.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/erythropoietin-epo-drugs-market

Further key findings from the study suggest:

The biologics segment is declining over the forecast period owing to patent expiration of branded biologics and introduction of biosimilars in the market
The patent for Aranesp (darbepoetin-alfa) will expire in 2024 in the U.S. and is expected to provide numerous future growth opportunities for new market entrants
Epoetin-alfa held the largest share of product segment owing to its early introduction in the U.S. market and patent protection
Epoetin-omega and epoetin-zeta are anticipated to exhibit lucrative growth over the forecast period owing to associated benefits such as longer half-life and enhanced therapeutic effects
Use of erythropoietin drugs for treatment of renal diseases held a dominant share as of 2016 owing to the increasing incidence of chronic kidney diseases
The Asia Pacific regional industry for erythropoietin-stimulating agents is expected to witness lucrative CAGR during the forecast period
Industry participants are focusing on the discovery of new therapeutic areas for existing drugs and development of cost-effective biosimilars, thereby increasing R&D activities for the development of erythropoietin drugs.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the erythropoietin (EPO) drugs market on the basis of the drug class, product, application, and region:

Erythropoietin Drugs Drug class Outlook (Revenue, USD Million, 2014 – 2025)

Biologics
Biosimilar

Erythropoietin Drugs Product Outlook (Revenue, USD Million, 2014 – 2025)

Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Erythropoietin Drugs Application Outlook (Revenue, USD Million, 2014 – 2025)

Cancer
Hematology
Renal Diseases
Neurology

Erythropoietin Drugs Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
- S.
- Canada
Europe
- Germany
- UK
Asia Pacific
- Japan
- China
- India
Latin America
- Brazil
- Mexico
MEA
- South Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-erythropoietin-epo-drugs-market

About Grand View Research

For more information visit – http://www.grandviewresearch.com/

ERP Software Market Size Was Valued At USD 27,648.0 Million In 2014 And Is Expected To Reach $48.22 Billion In 2022: Grand View Research, Inc.

July 31, 2017 / Market Research And Consulting Services / Leave a comment

Global ERP software market is anticipated to witness tremendous gains over the next seven years on account of its increasing application in defense & aerospace, retail, and government utility sectors. The software enables organizations to function with transparency, increases productivity, and enables decision making. The industry is expected to be worth USD 48.22 billion in 2022.

ERP software as a finance function facilitates management of different financial activities including cash flow management, asset management, accounting, and investment. Finance was the largest segment of the market contributing to over 22.0% of the share in 2014 and is estimated to grow at a CAGR exceeding 7.0% from 2015 to 2022.

Human resource is likely to be the fastest growing functional segment owing to rapid organizational development and expansion. Automated HR processes are also expected to drive growth.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/erp-software-market

Further key findings from the report suggest

On-premise ERP software deployment model accounted for over 60.0% of the total revenue in 2014, owing to the various benefits offered including high data security and continuous control in the organizations, thereby reducing the dependency on third party vendors. The market was valued at USD 17.01 billion in 2014. Cloud deployment was the second largest segment in 2014 owing to the introduction of mobile devices coupled with lower infrastructure requirements.
Manufacturing & services were valued at USD 5.11 billion in 2014, capturing over 15.0% of the revenue share in 2014. This segment utilizes ERP software for a broad range of business activities including customer services, inventory management, production scheduling, day-to-day performance management, daily operations monitoring and inter-departmental collaboration. Government utilities are expected to capture a significant share due to rising adoption of IT infrastructure.
Medium-enterprises were the largest end-users, accounting for over 40.0% of the global share in 2014, owing to the factors including minimized production costs, increased operational efficiency, and timely product delivery. Stringent government regulations and compliances in organizations have augmented market demand thereby, achieving high productivity and reduced complexity.
North America contributed to over 40.0% of the revenues in the global industry and was valued at USD 11.33 billion in 2014. Increasing technological advancements and rising adoption of ERP software in the finance function by the enterprises in the region to achieve transparency in financial transactions is expected to augment the market demand.
Europe and Asia Pacific are projected to register a speedy growth in the ERP software market owing to the mounting number of enterprises and booming manufacturing industry. Government initiatives, particularly in the emerging economies of Asia Pacific for implementing IT infrastructure are expected to augment the market demand over the forecast period. Key players present in the industry includes IBM Corporation, Oracle Corporation, SAP SE, Sage Group Plc, Syspro, Unit4, Microsoft Corporation and NetSuite Inc.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/communication-services

Grand View Research has segmented the global ERP software market on the basis of deployment, functions, verticals, end-user and region:

Global ERP Software Deployment Outlook (Revenue, USD Million, 2012 – 2022)

On-premise
Cloud

Global ERP Software Functions Outlook (Revenue, USD Million, 2012 – 2022)

Finance
Human resource (HR)
Supply chain
Others

Global ERP Software Verticals Outlook (Revenue, USD Million, 2012 – 2022)

Manufacturing & services
BFSI
Healthcare
Retail
Government utilities
Aerospace & defense
Telecom
Others

Global ERP Software End-User Outlook (Revenue, USD Million, 2012 – 2022)

Large enterprises
Medium enterprises
Small enterprises

Global ERP Software regions Outlook (Revenue, USD Million, 2012 – 2022)

North America
Europe
Asia Pacific
Rest of World

Access press release of this report – http://www.grandviewresearch.com/press-release/global-erp-software-market

About Grand View Research

For more information visit – http://www.grandviewresearch.com/

Epigenetics Market Will Grow Rapidly Based On Increasing Prevalence Of Cancer Till 2022: Grand View Research, Inc.

July 31, 2017 / Market Research And Consulting Services / Leave a comment

The global epigenetics market is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.

Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.

Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.

Technology advancements in the field of epigenetics especially pertaining to the detection of methylation markers related to cancer development is expected to improve usage rates during the forecast period. For instance, Epi proLung BL Reflex Assay by Epigenomics helps in the diagnosis of lung cancer by determining methylation of SHOX2 biomarker gene.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/epigenetics-market

Further key findings from the report suggest:

Epigenetic reagents was the largest market valued at over USD 1.2 billion in 2014 owing to the increasing amount of R&D investments and high consumption rates. Kits are expected to gain rapid growth in demand due to the increasing need of rapid and accurate detection techniques.
DNA methylation was the largest technology segment accounting for over 47.0% revenue in 2014. The introduction of technological advancement such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve diagnostics efficiency are some factors attributing for its largest share.
Oncology was the largest application market, with revenue valued at over USD 2.75 billion. Growing prevalence of cancer with epigenetic modification base and strong product pipeline are some factors attributing to its market position.
Non oncology segment is anticipated to register the fastest growth of over 20.0% during the forecast period. The segment is dominated by metabolic diseases owing to, the growing base of population suffering from diabetes and organ failure and increasing prevalence of sedentary lifestyle.
North America was observed to be the largest regional epigenetics market accounting for over 38.0% of the overall revenue, due to factors such as the increasing cancer prevalence, increasing amount of funding for R&D, growing collaborations between large pharmaceutical firms for development of improved therapeutics, high patient awareness levels.
The Asia Pacific market is estimated to witness lucrative growth over the forecast period owing to, the presence of large prevalence of target diseases and high unmet medical needs
Some key players of the epigenetics market include Illumina, Abcam, Diagenode, Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd, Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG, Oncolys Biopharma Inc., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich Corporation.
Extensive R&D initiatives aimed at the development of novel drugs and the presence of strong product pipeline is expected to further boost market growth over the forecast period.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global epigenetics market on the basis of product, technology, application and region:

Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)

Reagents
Kits
Instruments
Enzymes
Services

Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)

DNA Methylation
Histone Methylation
Histone Acetylation
Large noncoding RNA
MicroRNA Modification
Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)

Oncology
- Solid Tumors
- Liquid Tumors
Non Oncology
- Inflammatory Diseases
- Metabolic Diseases
- Infectious Diseases
- Cardiovascular Diseases

Epigenetics Market Regional Outlook(Revenue, USD Million, 2015 – 2022)

- North America
  - U.S.
  - Canada
- Europe
  - UK
  - Germany
- Asia Pacific
  - Japan
  - China
  - India
- Latin America
  - Brazil
  - Mexico
- Middle East and Africa (MEA)
  - South Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-epigenetics-market

About Grand View Research

For more information visit – http://www.grandviewresearch.com/

Erectile Dysfunction Drugs Market Will Grow Rapidly Based On Increasing Prevalence Of Conditions Such As Stress And Hypertension Till 2022

July 31, 2017 / Market Research And Consulting Services / Leave a comment

The global erectile dysfunction drugs market is expected to reach USD 3.2 billion by 2022 according to a new report by Grand View Research Inc. Rising adoption of sedentary lifestyle and increasing prevalence of conditions causing erectile dysfunction such as stress, hypertension, and related medications are the key factors expected to widen the target population base for this market.

However, the market is estimated to witness decline in revenue over the forecast period. Expiration of key drugs from 2017 to 2019 is likely to curb revenue growth. On the other hand, the market is likely to open up new avenues for the generic manufacturers to capitalize on. The increasing risk of sexually transmitted diseases, narrowing of insurance coverage for erectile dysfunction treatment, growing threat from counterfeit drugs, and presence of social stigma in developing countries are some factors limiting penetration rates.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/erectile-dysfunction-drugs-market

Further key findings from the report suggest:

Viagra accounted for over 47.0% of the total revenue in 2014. It is generally considered as the first line of treatment for erectile dysfunction. Brand loyalty and advantages associated with this drug such as high efficacy, and effectiveness are the major factors attributing for its large market share.
Cialis (tadalafil) from Eli Lilly & Co. and Levitra (vardenafil) from Bayer AG are known to be the competitors for Viagra globally. Cialis (tadalafil) was approved in 2003 by the U.S. FDA, as a prescription drug in the U.S. Cialis is also known as “The Weekend Pill” owing to its 36-hour effectiveness.
After the patent expiration of key drugs such as Cialis (tadalafil) in 2017 and Levitra (vardenafil) in 2018, other drugs such as Stendra/Spedra, Zydena (udenafil), and Vitaros (Alprostadil Cream) are expected to capture the market share during the forecasts period.
North America constituted the largest share of approximately 55.0% in 2013 of the total erectile dysfunction market. Extension of patent exclusivity rights for Viagra (sildenafil citrate) in the U.S. till 2019 along with introduction of new erectile dysfunction drugs such as Zydena (udenafil) and Stendra/Spedra (avanafil) will be the major factors responsible for market growth during the forecasts period.
Asia Pacific accounted for a revenue share of over 16.5% in 2012 owing to the presence of a lucrative market for generic drugs, untapped opportunities, and increasing awareness related to erectile dysfunction in this region
Apricus Biosciences Inc., Cristalia Produtos Quimicos Farmaceuticos Ltd., Bayer AG, Dong-A Pharmaceutical Co. Ltd., Meda Pharmaceuticals, Inc., Eli Lilly and Company, Pfizer, Inc., S.K. Chemicals Co. Ltd., and Vivus, Inc. are some major players of this market
Extensive R&D carried out by companies and high unmet needs in developing economies are expected to boost industrial growth. Key manufacturers are targeting regions with unmet clinical needs by entering into agreement with local manufacturers and distributors. Key players are constantly engaged in developing novel drugs in an attempt to improve the presence and ensure sustainability.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global erectile dysfunction drugs market on the basis of product and region:

Erectile Dysfunction Drugs Product Outlook (Revenue, USD Million, 2012 – 2022)

Viagra (sildenafil citrate)
Cialis (tadalafil)
Levitra/Staxyn (vardenafil)
Stendra/Spedra (avanafil)
Zydena (udenafil)
Vitaros (Alprostadil Cream)
Others

Erectile Dysfunction Drugs Regional Outlook (Revenue, USD Million, 2012 – 2022)

North America
Europe
Asia Pacific
RoW

Access press release of this report – http://www.grandviewresearch.com/press-release/global-erectile-dysfunction-drugs-market

About Grand View Research

For more information visit – http://www.grandviewresearch.com/

Proton Therapy Systems Market Is Projected To Grow At A CAGR Of 3.1% From 2014 To 2025: Grand View Research, Inc.

July 31, 2017July 31, 2017 / Market Research And Consulting Services / Leave a comment

The global proton therapy systems market is expected to reach USD 2.88 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of proton therapy centers, rising number of cancer cases, and growing investments by hospitals to establish these centers.

Growing funds & investments by hospitals, manufacturers, and private investors are also contributing to the growth of this market. For instance, in August 2015, Mevion Medical Systems (U.S.) raised USD 200 million in an equity funding led by HOPU Investments (China) and YuanMing Capital (China). These funds are likely to be used for development of technologically advanced and low-cost products. Furthermore, governments across various geographies are including budgets for establishment of these centers. For instance, in July 2015, the state government of Victoria included nearly AUD 2 million (USD 1.53 million) to develop a National Centre for Proton Beam Therapy at the Victorian Comprehensive Cancer Centre (VCCC). The new center is expected to offer treatment to the patients in Australia.

In addition, rapid increase in the number of cancer cases globally is anticipated to bolster market growth during the forecast period. According to American Cancer Society, an estimated 1,688,780 new cancer cases are expected to be diagnosed in the U.S. and this disorder is likely to cause nearly 600,920 deaths in 2017. Furthermore, according to The Lancet, the number of women diagnosed with breast tumors is estimated to reach 3.2 million by 2030, which is almost double of 1.7 million in 2015.

Favorable reimbursement policies in the U.S and European countries and rising cancer-related healthcare expenditure in emerging nations is likely to propel the global market. In addition, decreasing cost of proton therapy, increasing awareness, and rising adoption are expected to boost demand for these systems during the forecast period. However, high costs involved in the establishment of these centers and lack of reimbursement in emerging nations is likely to restrain growth in the coming years.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/proton-therapy-systems-market

Further Key Findings From the Report Suggest:

The equipment segment held majority of the revenue share in 2016 due to rise in the number of contracts for establishment of proton therapy centers
North America dominated the global market owing to strong reimbursement framework and high adoption of this therapy
Some of the key players areMevion Medical Systems; IBA, Optivus Proton Therapy, Inc.; Advanced Oncotherapy plc; Varian Medical Systems, Inc.; Hitachi, Ltd.; and Mitsubishi Corporation.
The single-room systems segment is expected to command the largest share of the market in 2025.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the proton therapy systems market on the basis of product, type, and region:

Proton Therapy Systems Product Outlook (Revenue, USD Million, 2014 – 2025)

Equipment
Services

Proton Therapy Systems Type Outlook (Revenue, USD Million, 2014 – 2025)

Single-Room Systems
Multi-Room Systems

Proton Therapy Systems Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
- S.
- Canada
Europe
- Germany
- UK
Asia Pacific
- China
- Japan
Latin America
- Brazil
- Mexico
Middle East & Africa
- South Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-proton-therapy-systems-market

About Grand View Research

For more information visit – http://www.grandviewresearch.com/

Paints And Coatings Market To Witness Significantly Growth Owing To Its Rising Utilization In Various End-Use Industries Such As Automotive And Marine Till 2025

July 31, 2017 / Market Research And Consulting Services / Leave a comment

The global paints and coatings market is anticipated to exceed USD 227.70 billion by 2025, according to a new report by Grand View Research, Inc. The global market is anticipated to achieve moderate growth over the forecast period. The demand of these products globally is expected to increase owing to growth of applications from end-use industries, architecture segment, regional demand, changing consumer preference for bio based products and technological advancements.

Increasing applications from end-use industries such as aerospace, automotive, general industries, marine and wood have augmented the growth of the market. Architectural sector is the other parameter that has majorly driven the global industry. The growth of architectural coats is attributed to growing construction spending in emerging regions.

The industry is a highly regulated industry due to presence of volatile organic compounds in these products which are harmful for the environment. However, the industry has witnessed a huge shift towards green and bio-based products in the form of powder based and waterborne formulations.

Waterborne coatings were the largest product segment in 2016 with demand of over 17.0 kilo tons in 2016 and is expected grow substantially over the forecast period owing to increasing demand from several application segments including construction, furniture and automobile industries. Product demand is anticipated to increase owing to increased construction spending and consumer preference especially in developed nations of Asia Pacific region for eco-friendly formulations.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/paints-coatings-market

Further key findings from the report suggest:

Global paints and coatings demand was 45.40 million tons in 2016 and is expected to grow with a CAGR of around 4.2% to reach a total volume of 65.81 million tons by 2025
Polyurethane is projected to be the fastest growing material segment in the industry
Architectural segment was the largest end-use segment however it is expected to grow moderately over he forecast period
General industrial sector is expected to emerge as the largest non-architectural end-use segment by 2025
The market in Central and South America is anticipated to grow at a CAGR of over 5% from 2017 to 2025
Technological advancements attributing to the growth of coats & vanishes include products manufactured by Nano technology and Fluro-additives. These innovative products provide enhanced application outcomes due to their excellent properties and enhanced tolerance levels towards weather-ability as compared to other conventional counterparts.
Major global players operating in the industry include BASF SE, PPG Industries, Sherwin-Williams Company, AkzoNobel, Axalta Coating System, Valspar Corporation, Kansai Paint, RPM International Inc., Nippon Paint Holdings, and Jotun Group

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/paints-coatings-and-printing-inks

Grand View Research has segmented the global paints and coatings market on the basis of application:

Paints & Coatings Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

High solids/radiation curing
Powder coatings
Waterborne coatings
Solvent-borne coatings
Others

Paints & Coatings Material Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

Acrylic
Alkyd
Polyurethane
Epoxy
Polyesters
Others

Paints & Coatings Application Type Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

Architectural & Decorative
Non-architectural
- Automotive
- Wood
- General Industrial
- Marine
- Protective
- Others

Paints & Coatings Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

North America
- S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
Asia Pacific
- China
- Japan
- India
Central & South America (CSA)
Middle East & Africa (MEA)

Access press release of this report – http://www.grandviewresearch.com/press-release/global-paints-coatings-market

About Grand View Research

For more information visit – http://www.grandviewresearch.com/

Regenerative Medicine Market Will Witness Growth Based On Increased Prevalence Of Orthopedic And Other Aging-Related Disorders Till 2025: Grand View Research, Inc.

July 31, 2017 / Market Research And Consulting Services / Leave a comment

The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025, according to a new report by Grand View Research, Inc. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth.

Developments in biotechnology have enabled gaining in-depth knowledge pertaining to cell division and differentiation as well as the metabolism mechanism of various cells. This enriched knowledge, coupled with emergence of novel streams of biotechnology such as gene therapy and nanotechnology, further prospered use of cell-based technology in therapeutic treatment.

Well established regenerative approached for various dermatological indications exists since ages. Technological advances introduced scaffolds, matrices, and grafts engineered for faster regeneration and minimal surgical procedure.

Identification of ability of stem cells to develop into various different cell lines further propelled the advancements in regenerative medicine. Frequent media exposure due to regulatory as well as ethical controversies around embryonic stem cells has increased awareness among the masses. This encouraged researchers to explore and develop other potential fields for similar applications, such as induced pluripotent stem cells (iPSC).

Furthermore, the emergence of gene therapy techniques with potential to rectify and restore effects of gene mutations in cells is under development. Conditions caused due to Single Nucleotide Polymorphism (SNP) as well as mutations that induce degenerative characteristics are primarily targeted.

Biologics, individually or in combination with cells or devices, are explored to support regenerate the biological functions of cells, tissues, or organs. A number of combinatorial therapies to support chemotherapy and other cancer treatments by prevention as well as treatment for cancer relapse are in development phases.

In addition, rising prevalence of complicated degenerative disorders such as age-related macular degeneration, Alzheimer’s disease, and Parkinson’s disease, especially in the aging population resulted in high investments in R&D to develop therapeutic solutions.

Regenerative medicine grabs the attention of the healthcare industry owing to its promising applications along with significant advances in supportive fields including tissue engineering, stem cells, gene therapy, drug discovery and nanotechnology. For instance, 3D printing over scaffold with stem cells to restore structure as well as functional characteristics of biological cells, tissues, and organs.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market

Further key findings from the report suggest:

The global regenerative medicine demand exceeded USD 1.7 billion in 2016 and is expected to grow at a considerable rate over the forecast period owing to the presence of a strong looking product pipeline with anticipated commercializations just around the corner
Therapeutics emerged as the largest product segment in 2016 as it has a relatively high implementation and usage rate resulting in higher adoption
Global regenerative services demand for facilities such as tissue banks and cellular engineering tools is expected to drive demand in the segment
The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies with increased focus of dominant players in emerging economies is attributive to market growth. market.
Key players including Asterias Bio, Athersys, Integra LifeSciences Corpotation, and MiMedx are involved in complex technical cum financial partnerships with larger players in an attempt to expedite R&D

Read our blog on regenerative medicine market – http://www.grandviewresearch.com/blog/regenerative-medicine-market-size

Grand View Research has segmented the global regenerative medicine market on the basis of product, therapeutic category, and region:

Regenerative Medicine Product Outlook (Revenue, USD Million, 2014 – 2025)

Therapeutics & Devices
- Primary Cell-bases therapeutics
  - Dermatology
  - Musculoskeletal
  - Surgical
  - Dental
  - Others
- Stem Cell & Progenitor Cell-based therapeutics
  - Autologous
  - Allogeneic
  - Others
- Tools
- Banks
- Services

Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2014 – 2025)

Dermatology
Musculoskeletal
Immunology & Inflammation
Oncology
Cardiovascular
Ophthalmology
Others

Regenerative Medicine Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
- U.S.
- Canada
Europe
- Germany
- UK
Asia Pacific
- China
- Japan
Latin America
- Brazil
Middle East & Africa
- South Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-regenerative-medicine-market

About Grand View Research

For more information visit – http://www.grandviewresearch.com/

Dodecanedioic Acid Market Size To Represent USD 443.3 Billion Opportunity Globally by 2022: Grand View Research, Inc.

July 28, 2017 / Market Research And Consulting Services / Leave a comment

Global Dodecanedioic Acid (DDDA) Market is expected to reach USD 443.3 million by 2022, according to a new study by Grand View Research, Inc. Increasing demand for nylon 6,12 from various end-use industries including polymers, detergents and coatings is expected to drive DDDA market growth over the forecast period. In addition, increasing paints & coatings production is likely to fuel DDDA demand. Development of new coating technologies for the industrial paints has contributed to the growth of DDDA on account of its ability to resist corrosion and provide durable flexible coatings.

Penetration of DDDA in resin applications was highest in 2014, as it is used as a key raw material for manufacturing nylon. Increasing consumption of nylon 6,12 in automotive, electrics & electronics and construction is likely to drive DDDA market production. Growth of these end-use industries is anticipated to subsequently impact market growth in resin applications over the forecast period.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/dodecanedioic-acid-ddda-industry

Further key findings from the study suggest:

Asia Pacific was the largest market for DDDA accounting for over 35% of the global volume share in 2014 owing to the presence of a robust industrial base in the region. High potential for industrialization in the region is expected to drive demand for DDDA over the forecast period, making it a high growth market. Discovery of shale gas in the U.S. is expected to open new opportunities in lubricant applicatios in North America in the near future.
China was the largest producer and consumer of DDDA owing to the presence of a robust polymer and paint & coatings manufacturing base in the country. China accounted for over 25% of the global market volume in 2014 and is expected to maintain its lion’s share over the forecast period.
Global DDDA demand in adhesives was 3.3 kilo tons in 2014 and is expected to grow at a CAGR of over 5% from 2015 to 2022. Rising importance of high performance adhesives in industrial applications has resulted in growing demand for adhesives. Growth of major end use industries such as construction and automotive, mainly in countries such as China, India and Brazil is expected to drive the global adhesives and sealants market over the next six years.
Key players present in the global lignin market include Ube, Cathay Industrial Biotech, Verdezyne Inc., Evonik Industries AG, Invista and Santa Cruz Biotechnology Inc. the global industry is characterized by integration by numerous companies across various stages of the value chain. Verdezyne has established a bio-based DDDA plant in Malaysia and as per the company’s outlook, their plant can replace 30% of the global synthetic market.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/renewable-chemicals

For the purpose of this study, Grand View Research has segmented the global DDDA market on the basis of application and region:

Global DDDA Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2022)

Resins
Powder coatings
Adhesives
Lubricants
Others

Global DDDA Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2022)

North America
- S.
Europe
- Germany
- UK
Latin America
Asia Pacific
- China
- India
MEA

Access press release of this report – http://www.grandviewresearch.com/press-release/global-dodecanedioic-acid-market

About Grand View Research

For more information visit – http://www.grandviewresearch.com/

RFID Smart Cabinet Market To Gain From Rising Need For Inventory Management In Hospitals Till 2025: Grand View Research, Inc.

July 28, 2017 / Market Research And Consulting Services / Leave a comment

The global Radio-frequency identification (RFID) smart cabinet market is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. Globally, growing need for inventory management in hospitals has led to increased demand and thereby market growth.

Furthermore, advantages associated with RFID smart cabinets such as accuracy, real-time tracking, and lesser inventory waste and equipment losses. All the above factors, decreases the operational cost of hospitals and hence number of hospitals across the globe started to adopt RFID smart cabinets for tracking of various items.

North America dominated the Radio-frequency identification smart cabinet market due to the local presence of market players, government initiatives, availability of innovative products, and advanced healthcare infrastructure. For instance, in March 2015, SATO, a provider of auto-id solutions published their new SATO PJM RFID Smart Cabinet at an annual meeting of the American Academy of Orthopaedic Surgeons, 2015. Other than orthopedic, the device is applicable in management of diamonds. Pharmaceuticals, and other high-value items.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/rfid-industry

Further Key Findings From the Report Suggest:

Increasing demand of Radio-frequency identification smart cabinet across the globe is expected to propel growth at the strong rate with a CAGR of 11.9% from 2017 to 2025
The U.S. accounted for the largest share in North America due to local presence of market players and government support for the better infrastructure in healthcare. WaveMark Inc., Terso Solutions, Mobile Aspects, and Solstice Medical are some of the major players in the U.S.
The industry in Asia Pacific is projected to witness strongest growth during the forecast period owing to growing investment by several clinics and pharmaceutical companies, increasing healthcare expenditure, and rising awareness about RFID smart cabinet. This region is expected to grow at a CAGR of 13.5% from 2017 to 2025.
India is expected to observe the largest growth in Asia Pacific due to implementation of supportive regulations, growing awareness, and increasing export due to compliance with global standards and cost effectiveness of devices.
Economical development in Latin America and investment by pharmaceutical and medical devices companies are likely to propel the market growth. Furthermore, free trade agreements and proximity to North America helps to boost the market growth.
Some key major players include WaveMark, Terso Solutions, Solstice Medical, Mobile Aspects, LogiTag, Tagsys, and GRIFOLS. The market is dominated by the regional players and competing on the basis of price and technology. Increasing adoption of RFID smart cabinets in hospitals along with the pharmaceutical and medical device companies to track the product is likely to drive the market in coming years.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global RFID smart cabinet market on the basis country:

RFID Smart Cabinet Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
- S.
- Canada
- Mexico
Europe
- Belgium
- Poland
- Netherlands
- Spain
- Germany
- K.
- France
Asia Pacific
- Japan
- China
- India
- Australia
Central & South America
- Brazil
- Argentina
- Chile

Middle East & Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-rfid-smart-cabinets-market

About Grand View Research

For more information visit – http://www.grandviewresearch.com/

market research and reports

reports analysis, share and marketing

Month: July 2017

Erectile Dysfunction Drugs Market Will Grow Rapidly Based On Increasing Prevalence Of Conditions Such As Stress And Hypertension Till 2022

Dodecanedioic Acid Market Size To Represent USD 443.3 Billion Opportunity Globally by 2022: Grand View Research, Inc.